Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Provide Multi-Year Genotyping Services to GlaxoSmithKline

NEW YORK, Sept. 22 (GenomeWeb News) -- Illumina will provide further genotyping services for GlaxoSmithKline, the company said today.


Under the multi-year agreement, Illumina will use its Sentrix arrays as well as its GoldenGate and Infinium assays to analyze several thousand samples provided by GSK, which are part of several projects.


Illumina, which did not provide further details on the agreement, has already been providing genetic analyses for GSK since June 2001.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.